You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康恩貝(600572.SH):控股股東擬轉讓所持20%股份 實控人擬變更為浙江省國資委
格隆匯 05-29 17:51

格隆匯5月29日丨康恩貝(600572.SH)公佈,2020年5月29日,公司接控股股東康恩貝集團公司函告,為推進在醫藥大健康產業尤其是中醫藥健康產業領域的戰略合作,以上市公司浙江康恩貝製藥股份有限公司為主體合作共建“浙江省中醫藥健康產業主平台”,康恩貝集團公司與省國貿集團全資子公司省中醫藥健康產業集團於2020年5月28日簽訂了《康恩貝集團有限公司與浙江省中醫藥健康產業集團有限公司關於浙江康恩貝製藥股份有限公司之股份轉讓協議》。

康恩貝集團公司擬向省中醫藥健康產業集團轉讓所持有的公司5.33億股股份,佔公司總股本的20%。若本次股份轉讓實施完成,康恩貝集團公司將持有公司股份1.74億股、佔公司總股本的6.52%,康恩貝集團公司及其一致行動人胡季強、浙江博康醫藥投資有限公司將合計持有公司13.33%的股份;省中醫藥健康產業集團將持有公司20%的股份,成為公司的控股股東,公司將成為省國貿集團實際控制的上市公司。公司實際控制人將由胡季強變更為浙江省國資委。

截至本公告日,康恩貝集團有限公司持有公司股份7.07億股,佔公司總股本的26.52%,均為無限售條件流通股。累計質押公司股份1.82億股,佔持有股份數的25.85%,佔公司總股本的6.85%。上述股票質押事項有可能造成本次交易無法繼續推進的風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account